on ARCHOS (EPA:ALJXR)
POLADERME nominated for the “Best start-up” prize from the Galien Foundation
Paris, August 27, 2024 – ARCHOS announces that POLADERME, a subsidiary of the group’s Medtech Startup studio, has been nominated for the “Best start-up” award from the Galien Foundation. This global institution honors innovators in the life sciences.
The Galien Foundation aims to encourage, recognize and reward excellence in scientific innovation, with the aim of improving human health. Its overall commitment is measurable and concrete. The “Best Start-up” award is in partnership with Business France.
Kenneth C. Frazier, Chair of the Medical Technology Committee, highlighted the nominees' dedication to innovation. Loïc Poirier, President of POLADERME, said he was honored by this prestigious recognition.
The winner will be announced on November 7 at the Prix Galien USA Awards ceremony at the Museum of Natural History in New York.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ARCHOS news